Cell proliferation is defined as an increase in the number of cells due to cell growth and cell division. The rate of cell proliferation depends on the rate of cell division and the portion of cells within a given population undergoing such division, as well as the rate of cell loss due to apoptosis. The aforementioned rate of cell division is regulated by the cell cycle, which is divided into S phase, M phase, G1 phase, G2 phase and G0 phase (a non-dividing state). Abnormal cell proliferation, commonly referred to as neoplasia, is a necessary mechanism but may also lead to tumorigenesis. There is an important balance between cell proliferation and apoptosis for the development of normal tissues.
Cell Proliferation Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Cell Proliferation below!
For more information on how to use Laverne, please read the How to Guide.
We have 4755 products for the study of the Cell Proliferation Pathway that can be applied to Chromatin Immunoprecipitation, Western Blot, Flow Cytometry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry, Chromatin Immunoprecipitation (ChIP) from our catalog of antibodies and ELISA kits.
PRODUCT AVAILABILITY: Update Regarding the Evolving COVID-19 Situation
Bio-Techne appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of products and services. Currently, and as we abide by local shelter in place orders across the world, we are fully operational and do not anticipate any material supply disruptions across our Bio-Techne brands and product lines. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.